Health News

Pfizer-BioNTech's Covid-19 Vaccine Proves 95% Effective In Final Trials, Will Reach FDA For Emergency Use Authorization

Haryana: 72 Students In Rewari, 11 Pupils & 8 Teachers In Jind Test Positive For Covid-19 After Schools Reopen

Chapare Virus: Another Deadly Virus On The Rise? Know All About The Ebola Like Virus In Bolivia

Covid Vaccine: Which Countries Are In Line For Moderna And Pfizer Vaccine? Know Where India Stands

Coronavirus Surge: Random Testing To Be Done At Delhi-Noida Border; All You Need To Know

Vaccine Update: Bharat Biotech Begins Phase 3 Trials Of Covaxin; Here Are the Latest Updates

Delhi Coronavirus: Kejriwal Proposes A ‘Local Level’ Lockdown For Crowded Markets If Covid-19 Cases Rise Further

Covid-19 Vaccine: Understanding Pfizer & Moderna’s Claims About Breakthrough | Know What Vaccine Effectiveness Means

'No Lockdown Again': Delhi Health Minister Says Third Wave Of Covid-19 Has Passed Its Peak

Face Masks & Social Distancing Compulsory, Physical Offering Of 'Prasad' Prohibited: Check SOPs For Religious Places Opening In Maharashtra

Covid-19 Vaccine Update: First Batch Of Russia 'Sputnik V' Expected To Reach Kanpur Next Week For Phase 2, 3 Clinical Trials

Coronavirus: Amid Diwali Celebrations, Delhi Records Another Spike In Daily Cases With 7,802 New Infections; Kejriwal Blames Rising Air Pollution

India May Get 100 Million Doses of Oxford’s Coronavirus Vaccine 'Covishield' By December

Microsoft Alleges Hackers From Russia, North-Korea Trying To Steal Covid Vaccine Research Data

Coronavirus: Delhi Reels Under Worst Covid-19 Onslaught, Shatters Record For Single-Day Deaths

Delhi HC Lifts Stay On AAP Govt's Order Reserving 80% ICU Beds For Covid-19 Patients

Maharashtra: Second Covid-19 Wave May Hit In Jan-Feb; Govt Braces Itself, Lists Preventive Steps

Vaccine Update: Serum Institute Completes Enrolment For Phase 3 Trials Of Oxford Covid-19 Vaccine

Will Pfizer’s Covid-19 Vaccine Become Available In India Soon? Know All About It

Alert! Delhi-NCR's Air Quality Heading Towards 'Emergency' Level

Covid-19 Vaccine 90% Effective In Phase 3 Trial, Says US Pharma Giant Pfizer